FDA Creates Division To Support First Amendment Policy Development, Oversee Advertising Research
Executive Summary
Multiple unfavorable court decisions have forced the agency to adjust its advertising enforcement strategies.
You may also be interested in...
FDA Authorized COVID Drugs Get New Advertising Abilities, Likely Necessitated By First Amendment
Pfizer and Merck indicate they may take advantage of new FDA decision that will give companies more flexibility to tout clinical trial results of COVID-19 therapeutics granted emergency use authorization.
Pfizer’s Paxlovid And The Murky World Of Rx Drug Communication
Pfizer social media announcement that it’s seeking full approval for the oral COVID antiviral raise questions about where the line is on promotion versus other communications, FDA’s ability to regulate pharma on social media, and the unique considerations of promotion under EUAs.
Pfizer’s Paxlovid And The Murky World Of Rx Drug Communication
Pfizer social media announcement that it’s seeking full approval for the oral COVID antiviral raise questions about where the line is on promotion versus other communications, FDA’s ability to regulate pharma on social media, and the unique considerations of promotion under EUAs.